PAREXEL and Salem State University Launch Clinical Trial Management Graduate Program
WALTHAM, Mass., Sept. 20, 2012 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced a partnership with Salem State University to offer a Post Graduate Certificate Program in Clinical Trial Management. This collaboration will provide candidates with the education needed to succeed in the growing clinical research management industry.
PAREXEL is committed to developing the future biopharmaceutical workforce with courses specifically tailored to meet the growing talent needs of the clinical development job market. Salem State University is an ideal partner to help further this effort due to its experience in developing academic programs relevant to workforce needs in the healthcare and life science fields.
"Salem State has a progressive outlook in partnering with industries and an impressive track record in building career interest in science disciplines," said Josef von Rickenbach, Chairman and Chief Executive Officer, PAREXEL International. "PAREXEL has experienced rapid growth in the United States and we are excited to have a major university partner in the Northeast to further develop the much-needed talent pool of candidates in the field."
"Our partnership with PAREXEL International is a strong example of Salem State's commitment to working with industry to create workforce aligned programs," said Patricia Maguire Meservey, president of Salem State University. "There is a clear need here for people with a healthcare or life sciences background who, with the right training, can tap into a specialized area where there is great demand."